D-0582-2025 Class II Ongoing
FDA drug recall D-0582-2025 was initiated by Westminster Pharmaceuticals LLC on Aug 6, 2025 and is designated Class II. Reason for recall: CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level. The recall status is ongoing. Affected quantity: 4,456 1000-count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 20, 2025
- Initiation Date
- Aug 6, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4,456 1000-count bottles
Product description
Metoprolol Tartrate Tablets, USP, 100 mg, 1000 Tablets, Rx Only, Manufactured by: Renata PLC (General Plant -2), Noyapara, Bhawal Mirzapur, Rajendrapur, Gazipur, 1700 Bangladesh, Distributed by: Westminster Pharmaceuticals, LLC, Nashville, TN 37217, NDC 69367-355-10
Reason for recall
CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.
Distribution pattern
Nationwide in the USA.
Code information
Batch # R56240011, Exp Date: 2/28/26; Batch # R56240021, R56240031, Exp Date: 3/31/26; Batch # R56240041, R56240051, R56240061, Exp Date: 4/30/26; Batch # R56240071, Exp Date: 7/31/26
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0582-2025
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026